1-9 of 9
Andreas Kulozik
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improvement in Iron Burden in Patients with Transfusion-Dependent β-Thalassemia (TDT) Treated with Betibeglogene Autotemcel (Beti-cel) Gene Therapy: Up to 9 Years of Follow-up

Janet L. Kwiatkowski, Timothy S. Olson, Mark C. Walters, John B. Porter, Jennifer Schneiderman, Suradej Hongeng, Andreas Kulozik, Marina Cavazzana, Martin G. Sauer, Adrian J. Thrasher, Isabelle Thuret, Ashutosh Lal, John E. J. Rasko, Evangelia Yannaki, Shamshad Ali, Gloria Tao, Ami Deora, Himal L. Thakar, Richard A. Colvin, Franco Locatelli, Alexis A. Thompson
Journal: Blood
Blood (2023) 142 (Supplement 1): 2480.
https://doi.org/10.1182/blood-2023-173869
Published: 2023
Journal Articles

Drug Response Profiling Informs Personalized Bridging to Cell Therapy for Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

Fabio D. Steffen, Andrej Lissat, Julia Alten, Cornelia Eckert, Nicole Bodmer, Bodil E. Thorhauge Als-Nielsen, Adriana Balduzzi, Barbara Buldini, Sarah Elitzur, Andras Kriston, Gergely Nyiri, Imre Västrik, Ferenc Kovacs, Francesco Ceppi, Lucie Sramkova, Larissa Schori, Arianna Arpagaus, Silvia Gutnik, Andishe Attarbaschi, Birgitte Klug Albertsen, Jeanette Greiner, Marc Ansari, Judith M. Boer, Elad Jacoby, Martin Stanulla, Uri Ilan, Peter M. Hoogerbrugge, Tim Lammens, Barbara De Moerloose, Petter Svenberg, Nicolas von der Weid, David O'Connor, Hélène Cavé, Franco Locatelli, Martin Schrappe, André Baruchel, Andreas Kulozik, Kjeld Schmiegelow, Gunnar Cario, Arend von Stackelberg, Peter Horvath, Beat Bornhauser, Jean-Pierre Bourquin
Journal: Blood
Blood (2023) 142 (Supplement 1): 4350.
https://doi.org/10.1182/blood-2023-179306
Published: 2023
Journal Articles

Easyab Unravels Oncokinase Driven Regulation of Splicing Factors in AML

Ashok Kumar Jayavelu, Maithreyan Kuppusamy, Lavanya Mokada Gopal, Joris Frenz, Matthias Mann, Noelle Jung, Andreas Kulozik
Journal: Blood
Blood (2023) 142 (Supplement 1): 1383.
https://doi.org/10.1182/blood-2023-173914
Published: 2023
Journal Articles

Sustained Efficacy, Safety, and Improved Quality of Life in Adult and Pediatric Patients with Transfusion-Dependent β-Thalassemia up to 9 Years Post Treatment with Betibeglogene Autotemcel (Beti-cel)

Alexis A. Thompson, Timothy S. Olson, Mark C. Walters, John B. Porter, Jennifer Schneiderman, Suradej Hongeng, Andreas Kulozik, Marina Cavazzana, Martin G. Sauer, Adrian J. Thrasher, Isabelle Thuret, Ashutosh Lal, John E. J. Rasko, Evangelia Yannaki, Shamshad Ali, Gloria Tao, Himal L. Thakar, Ami Deora, Katiana Gruppioni, Richard A. Colvin, Franco Locatelli, Janet L. Kwiatkowski
Journal: Blood
Blood (2023) 142 (Supplement 1): 1102.
https://doi.org/10.1182/blood-2023-174068
Published: 2023
Journal Articles

BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis

e-blood
Felix Sahm, David Capper, Matthias Preusser, Jochen Meyer, Albrecht Stenzinger, Felix Lasitschka, Anna-Sophie Berghoff, Antje Habel, Marion Schneider, Andreas Kulozik, Ioannis Anagnostopoulos, Leonhard Müllauer, Gunhild Mechtersheimer, Andreas von Deimling
Journal: Blood
Blood (2012) 120 (12): e28–e34.
https://doi.org/10.1182/blood-2012-06-429597
Published: 2012
Includes: Supplemental data
Journal Articles

The Favorable Effect of Activating NOTCH1 Receptor Mutations On Long Term Outcome in T-ALL Is Treatment Related and Can Be Separated From NOTCH Pathway Activation by FBXW7 Loss of Function.

Corinne Kox, Martin Zimmermann, PhD, Martin Stanulla, MD, Martin Schrappe, MD, Wolf-Dieter Ludwig, Rolf Koehler, PhD, Svenja Leible, Gabriele Tolle, Obul Reddy Bandapalli, Stephen Breit, Martina Ulrike Muckenthaler, Andreas Kulozik, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 908.
https://doi.org/10.1182/blood.V114.22.908.908
Published: 2009
Journal Articles

High-Resolution Genomic Profiling (array-CGH) of Childhood T-ALL Identifies Deletions at 6q15-16.1 as a Predictive Marker for Early Treatment Response.

Marc Remke, Stefan Pfister, Martin Stanulla, Martin Schrappe, Martina Ulrike Muckenthaler, Peter Lichter, Andreas Kulozik
Journal: Blood
Blood (2008) 112 (11): 1484.
https://doi.org/10.1182/blood.V112.11.1484.1484
Published: 2008
Journal Articles

Notch Pathway Activation by a Combination of Activating NOTCH1 -Receptor and Inactivating FBXW7 Mutations Robustly Predicts Excellent Early Treatment Response in Pediatric T-ALL.

Corinne Kox, Svenja Leible, Stephen Breit, Martin Stanulla, MD, Martin Schrappe, MD, Martina Ulrike Muckenthaler, Andreas Kulozik
Journal: Blood
Blood (2008) 112 (11): 1493.
https://doi.org/10.1182/blood.V112.11.1493.1493
Published: 2008
Journal Articles

The Early Treatment Response of the Clinically Challenging Group of Childhood T-ALL without NOTCH1 Mutations Is Signified by a Specific mRNA Gene Profile.

Andreas Kulozik, Stephen Breit, Stefan Pfister, Shangyou Liu, Martin Stanulla, Martin Schrappe, Wolf-Dieter Ludwig, Ulrike Köhl, Arndt Borkhardt, Renate Kirschner-Schwabe, Martina U. Muckenthaler
Journal: Blood
Blood (2007) 110 (11): 2789.
https://doi.org/10.1182/blood.V110.11.2789.2789
Published: 2007